腺泡杆菌

Acinetobacter baumannii is a common nosocomial pathogen.
鲍曼不动杆菌是一种常见的医院获得性病原体。
The antibiotic resistance of Acinetobacter is a major concern in healthcare settings.
鲍曼不动杆菌对抗生素的耐药性是医疗环境中的一大关注点。
Acinetobacter causes skin and respiratory infections in patients with compromised immune systems.
鲍曼不动杆菌会导致免疫系统受损患者的皮肤和呼吸道感染。
It's crucial to maintain proper hygiene in hospitals to prevent Acinetobacter outbreaks.
在医院保持良好的卫生至关重要，以防止鲍曼不动杆菌的爆发。
Acinetobacter spp. can survive on surfaces for weeks, making it challenging to eradicate.
鲍曼不动杆菌属能在表面存活数周，使其难以根除。
Researchers are studying the biofilm formation of Acinetobacter to better understand its persistence in medical environments.
研究人员正在研究鲍曼不动杆菌的生物膜形成，以便更好地理解其在医疗环境中的持久性。
The use of disinfectants with high efficacy against Acinetobacter is essential in combating hospital-acquired infections.
使用能有效对抗鲍曼不动杆菌的消毒剂对于对抗医院获得性感染至关重要。
Patients receiving long-term care are more susceptible to Acinetobacter colonization.
接受长期护理的患者更容易被鲍曼不动杆菌定植。
Acinetobacter infections often require multidrug therapy due to its extensive resistance profile.
鲍曼不动杆菌感染通常需要多药疗法，因为其广泛的耐药性。
Advances in molecular biology have helped identify new targets for treating Acinetobacter infections.
分子生物学的进步有助于识别治疗鲍曼不动杆菌感染的新靶点。